these agonists raise HDL but can also raise hepatic triglycerides levels, which might adversely affect HDL function PPARγ agonists (thiazolidinediones) Increase apoA-I synthesis; effective in ...
A small study of Sanofi’s lixisenatide has suggested that the GLP-1 agonist could slow down the progression of Parkinson’s disease, pointing to another potential use for the fast-growing drug ...
Clin Lipidology. 2014;9(1):101-118. TAUSSIG: a multicenter, open-label study to assess the long-term safety, tolerability, and efficacy of AMG145 on LDL-C in subjects with severe familial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback